Old Web
English
Sign In
Acemap
>
authorDetail
>
Di Bei
Di Bei
Bristol-Myers Squibb
Biology
Internal medicine
Oncology
Cancer research
Nivolumab
1
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Benefit‐risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers
2019
Cancer Science
Di Bei
Mayu Osawa
Shinji Uemura
Tomoya Ohno
Jogarao V. S. Gobburu
Amit Roy
Mayumi Hasegawa
Show All
Source
Cite
Save
Citations (3)
1